Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alberto Morell
Observed names:
A Morell,
A. Morell
Institutions:
Universidad San Pablo CEU,
Hospital Universitario de La Princesa,
Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa
Observed institutions:
Universidad San Pablo CEU,
Madrid Health Service,
Hospital Universitario de La Princesa,
Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa
ORCID:
0000-0003-4937-4292
Observed ORCID:
0000-0003-4937-4292
OpenAlex ID:
A5013872522
IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study
2020
·
José María Galván-Román
, Sebastián C. Rodríguez-García
, et al.
·
Journal of Allergy and Clinical Immunology
·
231
PDF
Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients
2021
·
Diego A. Rodríguez-Serrano
, Emilia Roy-Vallejo
, et al.
·
Scientific Reports
·
41
PDF
Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel Disease
2019
·
M Chaparro
, A Garre
, et al.
·
Journal of Crohn s and Colitis
·
35
PDF
Longitudinal Study of Therapeutic Adherence in a Cystic Fibrosis Unit: Identifying Potential Factors Associated with Medication Possession Ratio
2022
·
Rosa Mª Girón
, Adrián Peláez
, et al.
·
Antibiotics
·
12
PDF
Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain
2021
·
J. Martinez-Ubieto
, C. Aragón- Benedí
, et al.
·
BMC Anesthesiology
·
10
PDF
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
2019
·
María Chaparro
, María G. Donday
, et al.
·
Therapeutic Advances in Gastroenterology
·
7
[Cost analysis of the use of botulinum toxin type A in Spain].
2014
·
F de Andrés-Nogales
, A Morell
, et al.
·
PubMed
·
7
DI-024 Cetuximab in the treatment of advanced metastatic colorectal cancer
2014
·
E Debén
, T Gallego
, et al.
·
European Journal of Hospital Pharmacy
·
7
Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study
2024
·
Esther Chamorro-de-Vega
, Alberto Calvo
, et al.
·
Farmacia Hospitalaria
·
4
Evaluation of the hospital care quality perceived by patients with immune‐mediated inflammatory diseases from the pharmacy service. SACVINFA study
2022
·
Esther Ramírez
, Rosa Romero‐Jiménez
, et al.
·
Journal of Clinical Pharmacy and Therapeutics
·
4
Ab0334 Cost-efectiveness of Jak Inhibitors in Rheumatoid Arthritis in the Real Worl Practice
2020
·
A. Calvo Garcia
, N. García Castañeda
, et al.
·
Annals of the Rheumatic Diseases
·
2
Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unit
2019
·
José María Alvaro-Gracia
, Miguel Arredondo
, et al.
·
Reumatología Clínica
·
2
Cost And Cost Per Responder In Spain of Adalimumab, Methotrexate And Apremilast In The Treatment of Methotrexate-Naïve Patients With Psoriatic Arthritis
2016
·
A Morell
, E Ramírez
, et al.
·
Value in Health
·
2
P508 Drug survival and reasons for discontinuation of anti-TNF therapy in inflammatory bowel disease (IBD) in clinical practice
2014
·
J.P. Gisbert
, M. Arredondo
, et al.
·
Journal of Crohn s and Colitis
·
1
Tratamiento biológico de la artritis reumatoide en España. Análisis de impacto presupuestario de la utilización de certolizumab pegol
2013
·
Álvaro Hidalgo
, Renata Villoro
, et al.
·
PharmacoEconomics Spanish Research Articles
·
1
PDF
Body Mass Index and Body Fat Percentage Are Associated with Clinical Outcomes in Patients Receiving PD-1/PD-L1 Inhibitors: A Prospective Exploratory Study
2026
·
Ángela Morell
, Alberto Morell
, et al.
·
Journal of Personalized Medicine
Ab1185 Patient-reported Experience in Immune Mediated Inflammatory Diseases (imid) in Thecontext of the Covid-19 Pandemic: Accessibility and Continuity of Care.
2022
·
J.P. Baldivieso
, E. Ramirez
, et al.
·
Annals of the Rheumatic Diseases
PDF
Ab0371 Long Term Rituximab Persistence for Rheumatoid Arthritis in the Real World: the Ritar Study
2019
·
Iciar Cañamares Orbis
, Leticia Merino-Meléndez
, et al.
·
Annals of the Rheumatic Diseases
PDF
Launch and Preliminary Analysis of Hospital de La Princesa's Inter-specialists Biological Therapies Unit
2019
·
José María Alvaro-Gracia
, Miguel Arredondo
, et al.
·
Reumatología Clínica (English Edition)
Psy52 - Economic Impact of Improving Patient Safety Using Sugammadex for Routine Reversal of Neuromuscular Blockade in Spain
2018
·
P. Ramirez Boix
, S. Cedillo Gomez
, et al.
·
Value in Health
FRI0146 Effectiveness of Retreatment After Relapse of Rheumatoid Arthritis Patients Under Down-Titrated Biological Therapy
2015
·
J.P. Vinicki
, M. Arredondo
, et al.
·
Annals of the Rheumatic Diseases
AB0403 Dose Optimization of Biological Therapies in Rheumatoid Arthritis in Clinical Practice
2014
·
M. Arredondo
, L. Sala
, et al.
·
Annals of the Rheumatic Diseases
AB0774 Does prescription year influence the pattern of biologics use for rheumatoid arthritis?
2013
·
J.M. Alvaro-Gracia
, M. Arredondo
, et al.
·
Annals of the Rheumatic Diseases
DGI-011 Anti-Tumor Necrosis Factor Real-World Doses: Four-Year Retrospective Study in Rheumatoid Arthritis Patients in Two Hospitals in Spain: Abstract DGI-011 Table 1
2013
·
E Alañón
, V Escudero
, et al.
·
European Journal of Hospital Pharmacy
PDF
Show more works
View as search
Works count:
24
Citation count:
366
H-index:
7
I10-index:
5
Year
Topic
Type